Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evoke Pharma

2.72
+0.03001.12%
Post-market: 2.720.00000.00%13:25 EDT
Volume:25.03K
Turnover:69.12K
Market Cap:4.06M
PE:-0.97
High:2.84
Open:2.78
Low:2.70
Close:2.69
Loading ...

Evoke Pharma Holds Annual Meeting via Webcast

TIPRANKS
·
23 May

Evoke Pharma Inc. Conducted Annual Remote Meeting via Webcast

Reuters
·
23 May

Evoke Pharma Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

BRIEF-Evoke Pharma Q1 Operating Expenses USD 4.4 Million

Reuters
·
14 May

Evoke Pharma Q1 EPS $(0.51) Misses $(0.33) Estimate, Sales $3.08M Miss $3.32M Estimate

Benzinga
·
14 May

Evoke Pharma Inc. Reports 77% Increase in Q1 2025 Net Product Sales to $3.1 Million; Operating Expenses Rise to $4.4 Million

Reuters
·
14 May

Evoke Pharma Inc: Reiterates Its 2025 Net Product Sales Guidance

THOMSON REUTERS
·
14 May

Evoke Pharma Q1 Operating Expenses USD 4.4 Million

THOMSON REUTERS
·
14 May

Evoke Pharma Inc expected to post a loss of 33 cents a share - Earnings Preview

Reuters
·
09 May

Jefferies Reaffirms Their Buy Rating on 888 Holdings (EVOK)

TIPRANKS
·
01 Apr

Evoke Pharma, Inc. (NASDAQ:EVOK) Just Reported And Analysts Have Been Cutting Their Estimates

Simply Wall St.
·
16 Mar

Evoke Pharma’s Earnings Call Highlights Revenue Growth and Strategic Partnerships

TIPRANKS
·
15 Mar

Evoke Pharma Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
15 Mar

Q4 2024 Evoke Pharma Inc Earnings Call

Thomson Reuters StreetEvents
·
15 Mar

Evoke Pharma Inc (EVOK) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans

GuruFocus.com
·
14 Mar

Evoke Pharma Reports Strong Revenue Growth in 2024

TIPRANKS
·
14 Mar

Evoke Pharma Q4 Sales $3.31M Beat $3.08M Estimate

Benzinga
·
14 Mar

Evoke Pharma Inc: Projects Net Revenue in 2025 of Approximately $16 Mln

THOMSON REUTERS
·
14 Mar

Evoke Pharma, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

GlobeNewswire
·
14 Mar

Evoke Pharma Inc expected to post a loss of 63 cents a share - Earnings Preview

Reuters
·
12 Mar